Developer docs
API playgroundTry for free, no card

Search company profiles

Coronado Research

Full company profile

uuid000c28y

Namestring
Coronado Research
Legal namestring
Coronado Research
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Coronado Research is a privately held biotechnology research services firm headquartered in Sevenoaks, United Kingdom. The company was founded in 2024 and operates with a very small team of 1-10 employees, indicating it is at an earliest-stage operational phase. The firm is led by Jennifer Visser-Rogers in the role of Chief Scientific Officer, providing the scientific leadership for its research services offering.

The company presents itself as a provider of biotechnology research services, though no further detail is available on the specific service lines, therapeutic areas, modalities, or client segments it serves. The source material does not disclose any products, proprietary technology, pricing model, customer references, partnership ecosystem, or funding history. Its operating website (coronado-research.com) is the only confirmed commercial artifact.

The business model is not described in the available data: no revenue model, pricing structure, or go-to-market motion is documented. With no disclosed revenue, no customer logos, and a founding year of 2024, Coronado Research appears to be in pre-revenue or very early commercialization stage. Investors or acquirers evaluating the firm should treat customer pipeline, revenue traction, and capital structure as key unverified items requiring direct diligence.

Short descriptiontext

Coronado Research is a UK-based, earliest-stage biotechnology research services firm founded in 2024, operating with 1-10 employees from Sevenoaks under CSO Jennifer Visser-Rogers. No products, customers, or revenue are disclosed.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSevenoaks, United Kingdom
HQ citystring
Sevenoaks
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
biotechnology research services, biotech consulting, life sciences research, biopharma advisory, scientific research support
Industry1 code
1Global Health Research, Clinical Trials & Product Development Partnerships (PDPs)
CodeHLAJAOAMPrimaryYes
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biotechnology Research Services
Social media profiles1 record
Cost components2 values
Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Coronado Research is a UK-based firm that offers biotechnology research services to clients in the life sciences sector. Operating as a small, privately held entity, the company delivers specialized research support to biotech organizations. Its offerings are rooted in scientific expertise rather than the development or sale of its own software or products.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Biotechnology Research Services
CategoryBiotechnology Research Services
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeBroad incumbent
Description

Global CRO and life sciences research services provider offering preclinical, discovery, and manufacturing services. Highly comparable to Coronado Research in core service category, but operates at vastly greater scale across the full biotech value chain.

TypeRegional player
Description

UK-based life sciences research organization providing drug discovery and development services to biotech sponsors. Highly comparable regional positioning to Coronado Research within the UK biotech ecosystem.

TypeDirect peer
Description

Clinical research and bioanalytical services firm specializing in early-stage clinical pharmacology for biotech and pharma. Comparable boutique-style biotech research services positioning to Coronado Research, though more established.

TypeBroad incumbent
Description

Independent CRO spun out of LabCorp providing clinical and biotech research services globally. Overlaps with Coronado Research's biotech research services focus across early- and late-stage programs.

TypeBroad incumbent
Description

Major global CRO providing clinical research, laboratory, and consulting services to biotech and pharma sponsors. Directly comparable in offering biotech research services, though operating at global scale.

TypeBroad incumbent
Description

World's largest CRO with end-to-end clinical and real-world research services. Competes for the same biotech sponsor R&D budget that Coronado Research targets, though at a much broader portfolio level.

TypeDirect peer
Description

Mid-size bioanalytical and biomarker services provider serving biotech sponsors. Closely comparable to Coronado Research in target customer profile and specialized life sciences research services orientation, with similar scope of lab and scientific work.

TypeBroad incumbent
Description

Large CRO focused on biotech and small-to-mid pharma sponsors, providing clinical research and consulting services. Comparable target customer base to Coronado Research, though with global delivery infrastructure.

TypeDirect peer
Description

Mid-tier CRO offering clinical research and bioanalytical services across multiple therapeutic areas. Directly comparable in providing biotech research services to small and mid-cap sponsors.

TypeEmerging player
Description

Asia-Pacific-focused CRO serving biotech sponsors with clinical and research services. Comparable in scale and biotech-only focus to Coronado Research, though operating across a different geographic base.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Coronado Research

Biotechnology Research Servicescoronado-research.com

Coronado Research is a UK-based, earliest-stage biotechnology research services firm founded in 2024, operating with 1-10 employees from Sevenoaks under CSO Jennifer Visser-Rogers. No products, customers, or revenue are disclosed.

What Coronado Research does

Coronado Research is a privately held biotechnology research services firm headquartered in Sevenoaks, United Kingdom. The company was founded in 2024 and operates with a very small team of 1-10 employees, indicating it is at an earliest-stage operational phase. The firm is led by Jennifer Visser-Rogers in the role of Chief Scientific Officer, providing the scientific leadership for its research services offering.

The company presents itself as a provider of biotechnology research services, though no further detail is available on the specific service lines, therapeutic areas, modalities, or client segments it serves. The source material does not disclose any products, proprietary technology, pricing model, customer references, partnership ecosystem, or funding history. Its operating website (coronado-research.com) is the only confirmed commercial artifact.

The business model is not described in the available data: no revenue model, pricing structure, or go-to-market motion is documented. With no disclosed revenue, no customer logos, and a founding year of 2024, Coronado Research appears to be in pre-revenue or very early commercialization stage. Investors or acquirers evaluating the firm should treat customer pipeline, revenue traction, and capital structure as key unverified items requiring direct diligence.

Coronado Research firmographics

Firmographics
Name
Coronado Research
Legal name
Coronado Research
Website
https://coronado-research.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
Coronado Research is a UK-based, earliest-stage biotechnology research services firm founded in 2024, operating with 1-10 employees from Sevenoaks under CSO Jennifer Visser-Rogers. No products, customers, or revenue are disclosed.
Ownership category
akta.pro rank

Coronado Research industry classification

Industry
Product category
Biotechnology Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

Keywords

  • Biotechnology research services
  • Biotech consulting
  • Life sciences research
  • Biopharma advisory
  • Scientific research support

Where Coronado Research is headquartered

Location

Headquarters

HQ city
Sevenoaks
HQ country
United Kingdom
HQ region
Europe

Markets served

Coronado Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations

Coronado Research product offering

Product offering

Core offering

Coronado Research is a UK-based firm that offers biotechnology research services to clients in the life sciences sector. Operating as a small, privately held entity, the company delivers specialized research support to biotech organizations. Its offerings are rooted in scientific expertise rather than the development or sale of its own software or products.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biotechnology Research Services

Companies that use Coronado Research

Customer profile

Ideal customer profiles1 record

Coronado Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Coronado Research partnerships and signals

Strategic signal

Recent moves2 records

Coronado Research competitors and assessment

Company assessment

Broad incumbents

  • Charles River Laboratories: Global CRO and life sciences research services provider offering preclinical, discovery, and manufacturing services. Highly comparable to Coronado Research in core service category, but operates at vastly greater scale across the full biotech value chain.
  • Fortrea (formerly LabCorp Drug Development): Independent CRO spun out of LabCorp providing clinical and biotech research services globally. Overlaps with Coronado Research's biotech research services focus across early- and late-stage programs.
  • ICON plc: Major global CRO providing clinical research, laboratory, and consulting services to biotech and pharma sponsors. Directly comparable in offering biotech research services, though operating at global scale.
  • IQVIA: World's largest CRO with end-to-end clinical and real-world research services. Competes for the same biotech sponsor R&D budget that Coronado Research targets, though at a much broader portfolio level.
  • Parexel: Large CRO focused on biotech and small-to-mid pharma sponsors, providing clinical research and consulting services. Comparable target customer base to Coronado Research, though with global delivery infrastructure.

Regional players

  • Catapult Medicines Discovery: UK-based life sciences research organization providing drug discovery and development services to biotech sponsors. Highly comparable regional positioning to Coronado Research within the UK biotech ecosystem.

Direct peers

  • Celerion: Clinical research and bioanalytical services firm specializing in early-stage clinical pharmacology for biotech and pharma. Comparable boutique-style biotech research services positioning to Coronado Research, though more established.
  • BioAgilytix Labs: Mid-size bioanalytical and biomarker services provider serving biotech sponsors. Closely comparable to Coronado Research in target customer profile and specialized life sciences research services orientation, with similar scope of lab and scientific work.
  • Worldwide Clinical Trials: Mid-tier CRO offering clinical research and bioanalytical services across multiple therapeutic areas. Directly comparable in providing biotech research services to small and mid-cap sponsors.

Emerging players

  • Novotech: Asia-Pacific-focused CRO serving biotech sponsors with clinical and research services. Comparable in scale and biotech-only focus to Coronado Research, though operating across a different geographic base.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat1 record

Key risks5 records

Key highlights3 records

Customer concentration

Coronado Research social profiles

Digital presence

Coronado Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Coronado Research leadership team

Management profile

Number of profiles

Profiles1 record

Coronado Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Coronado Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Coronado Research

What does Coronado Research do?

Coronado Research is a UK-based firm that offers biotechnology research services to clients in the life sciences sector. Operating as a small, privately held entity, the company delivers specialized research support to biotech organizations. Its offerings are rooted in scientific expertise rather than the development or sale of its own software or products.

Is Coronado Research a public or private company?

Coronado Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Coronado Research founded?

Coronado Research was founded in 2024. It employs 11 to 50 people.

Where is Coronado Research based?

Coronado Research is headquartered in Sevenoaks, United Kingdom, in the Europe region.

Who are Coronado Research's main competitors?

Broad incumbents on record are Charles River Laboratories, Fortrea (formerly LabCorp Drug Development), ICON plc, IQVIA and Parexel. Catapult Medicines Discovery is listed as a regional player. Direct peers are Celerion, BioAgilytix Labs and Worldwide Clinical Trials. Novotech is listed as an emerging player.

Does Coronado Research have an API?

No public API is recorded for Coronado Research.

What industry is Coronado Research in?

Coronado Research's product category is Biotechnology Research Services. Its primary akta.pro industry code is HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Drug Discovery World (DDW)The impact of AI on drug discovery and developmentDr Jennifer Bradford of Coronado Research discusses how artificial intelligence is transforming drug discovery and clinical development by enhancing human decision-making, shortening trial timelines, and reducing costs. Key applications include protein structure prediction through tools like AlphaFold, improved patient stratification using real-world data, and the integration of diverse datasets to support precision medicine. The article highlights that successful adoption requires overcoming barriers such as fragmented solutions and resistance to change through strong data foundations and robust AI governance.PR NewswireCoronado Research announce appointment of Jo Marshall as EVP Data Services and Advanced AnalyticsCoronado Research has appointed Jo Marshall as Executive Vice President of Data Services and Advanced Analytics. Marshall brings extensive experience in clinical development with a focus on data-driven outcomes and process optimization in drug development programmes. The appointment is intended to strengthen the company's ability to integrate clinical development and market access for pharmaceutical and biotechnology clients.PR NewswireCoronado Research Limited announce appointment of Professor Jennifer Visser-Rogers as Chief Scientific OfficerCoronado Research Limited has appointed Professor Jennifer Visser-Rogers as its new Chief Scientific Officer to lead its clinical research and drug development initiatives. In this role, she will leverage her expertise in data-driven methodologies and AI to optimize clinical trials and enhance service offerings for pharmaceutical clients.